Figure 3
From: Early diagnostic value of survivin and its alternative splice variants in breast cancer
Immunohistochemistry and confocal microscopy analysis of the survivin splice variants in breast cancer tissues: survivin (A, D), Survivin-∆ Ex3 (B,E), and Survivin-2B (C,F). The receptor status (ER + PR + Her2-) (A-C), and (ER + PR-Her+) (D-F). Original magnification is 20X. (ER, estrogen receptor; PR, progesterone receptor; Her2, human epidermal growth receptor type 2; α, antibody).